Department of Gastroenterology and Hepatology, University Hospital Frankfurt, Frankfurt, Germany.
Division of Virology, Paul Ehrlich Institute, Langen, Germany.
Liver Int. 2021 Jun;41(6):1278-1289. doi: 10.1111/liv.14884. Epub 2021 May 4.
BACKGROUND & AIMS: HBV genotype G (HBV/G) is mainly found in co-infections with other HBV genotypes and was identified as an independent risk factor for liver fibrosis. This study aimed to analyse the prevalence of HBV/G co-infections in healthy European HBV carriers and to characterize the crosstalk of HBV/G with other genotypes.
A total of 560 European HBV carriers were tested via HBV/G-specific PCR for HBV/G co-infections. Quasispecies distribution was analysed via deep sequencing, and the clinical phenotype was characterized regarding qHBsAg-/HBV-DNA levels and frequent mutations. Replicative capacity and expression of HBsAg/core was studied in hepatoma cells co-expressing HBV/G with either HBV/A, HBV/D or HBV/E using bicistronic vectors.
Although no HBV/G co-infection was found by routine genotyping PCR, HBV/G was detected by specific PCR in 4%-8% of patients infected with either HBV/A or HBV/E but only infrequently in other genotypes. In contrast to HBV/E, HBV/G was found as the quasispecies major variant in co-infections with HBV/A. No differences in the clinical phenotype were observed for HBV/G co-infections. In vitro RNA and DNA levels were comparable among all genotypes, but expression and release of HBsAg was reduced in co-expression of HBV/G with HBV/E. In co-expression with HBV/A and HBV/E expression of HBV/G-specific core was enhanced while core expression from the corresponding genotype was markedly diminished.
HBV/G co-infections are common in European inactive carriers with HBV/A and HBV/E infection, but sufficient detection depends strongly on the assay. HBV/G regulated core expression might play a critical role for survival of HBV/G in co-infections.
HBV 基因型 G(HBV/G)主要存在于与其他 HBV 基因型的合并感染中,被鉴定为肝纤维化的独立危险因素。本研究旨在分析欧洲 HBV 携带者中 HBV/G 合并感染的流行情况,并对 HBV/G 与其他基因型的相互作用进行特征分析。
通过 HBV/G 特异性 PCR 对 560 名欧洲 HBV 携带者进行 HBV/G 合并感染检测。通过深度测序分析准种分布,并通过 qHBsAg-/HBV-DNA 水平和常见突变来描述临床表型。通过共表达 HBV/G 与 HBV/A、HBV/D 或 HBV/E 的双顺反子载体,在肝癌细胞中研究 HBsAg/核心的复制能力和表达。
尽管常规基因分型 PCR 未发现 HBV/G 合并感染,但在感染 HBV/A 或 HBV/E 的患者中,通过特异性 PCR 检测到 4%-8%的患者存在 HBV/G。而在其他基因型中则很少见。与 HBV/E 不同,HBV/G 是 HBV/A 合并感染中的主要准种变异体。HBV/G 合并感染在临床表型上没有差异。所有基因型的 RNA 和 DNA 水平相似,但在与 HBV/E 共表达时,HBsAg 的表达和释放减少。在与 HBV/A 和 HBV/E 共表达时,HBV/G 特异性核心的表达增强,而相应基因型的核心表达则明显减少。
HBV/G 合并感染在感染 HBV/A 和 HBV/E 的欧洲非活动携带者中很常见,但充分检测强烈依赖于检测方法。HBV/G 调节的核心表达可能在 HBV/G 合并感染中的生存中起着关键作用。